79 Matching Annotations
  1. May 2017
    1. In the present study, we did not find a significant association between age and CAP due to GNB or P aeruginosa, corroborating the view that age does not represent an independent risk factor for these pathogens.

      unclear conclusions about whether age is enough immunosuppresion

    2. CAP due to GNB has often been reported to be more frequent in the elderly population, especially by American authors in the 1970s.26- 28 A corresponding high incidence of 16% was found in a series of severe CAP in the elderly.

      in the 1970s

    3. On the other hand, the value of sputum, tracheobronchial aspirates, and even bronchoscopically retrieved samples may be seriously questioned, especially in patients with structural lung disease such as COPD or bronchiectasis or even in patients with heavy cigarette use. Gram-negative bacteria may easily colonize the tracheobronchial tree in the presence of any alterations or damage of the respiratory epithelium

      Gram negative bacteria can colonize easier in a damaged respiratory tract, which relates to our case because our patient has been smoking for years

    1. These agents are bactericidal and exhibit synergy with other antimicrobials, most notably β-lactams, with which they are often administered for the treatment of Pseudomonas aeruginosa infections;

      you want to treat aminoglycosides with Beta-lactams

  2. textbookofbacteriology.net textbookofbacteriology.net
    1. The highest prevalence of multidrug-resistant strains was observed among isolates from lower respiratory tract infections

      our patient is infected in the lower respiratory tract so she's more in danger of having a multi-drug resistant infection

    2. P. aeruginosa can develop resistance to antibacterials either through the acquisition of resistance genes on mobile genetic elements (i.e., plasmids) or through mutational processes that alter the expression and/or function of chromosomally encoded mechanisms.

      drug resistance

    3. Unfortunately, selection of the most appropriate antibiotic is complicated by the ability of P. aeruginosa to develop resistance to multiple classes of antibacterial agents, even during the course of treating an infection.

      first line of treatment is hard to determind because it's develops resistance so quickly

    1. Gonococcal culture has low sensitivity (<50%) for detecting oropharyngeal gonorrhoea, and, although not yet approved commercially, nucleic acid amplification tests (NAAT) are the assay of choice.

      culture has low sensitivity so NAAT tests are preferred

  3. Apr 2017
    1. The susceptibility rates for S. sanguis were: penicillin, 74%; amoxicillin, 84%; ceftriaxone, 94%; clindamycin, 87%, and vancomycin, 100%. The susceptibility rates for S. mitis were: penicillin, 42%; amoxicillin, 67%; ceftriaxone, 58%; clindamycin, 100%; and vancomycin, 100%. The susceptibility rates for S. milleri were: penicillin, 100%, amoxicillin. 100%; ceftriaxone, 100%, clindamycin, 100%; and vancomycin, 100%.

      different antimicrobials that stop different species within the viridans streptococci group.

    1. viridans streptococcus  any of a group of streptococci with no defined Lancefield group antigens but not Streptococcus pneumoniae, usually α-hemolytic; part of the normal flora of the respiratory tract but also causing dental caries, bacterial endocarditis, and other disorders in immunocompromised hosts

      important way to distinguish viridans from others- no Lancefield antigens and usually a-hemolytic other than pneumoniae but gram stain should be able to differentiate because of gram-positive

    1. Alpha-hemolytic streptococci cause a partial or “greening” hemolysis around the colony, associated with the reduction of red cell hemoglobin.

      will help identify viridans from other streptococci groups because of the green colonies on blood agar plates

    1. Some scientists argue that it's equally important to analyze primary cases -- the person or animal that first brings a bacterium or virus into a population.

      In order to analyze primary cases, it's important to not stop at assuming that "patient zero" is the definite beginning and cause of a symptom. Scientists have to question the "patient zero" idea because diseases most likely have multiple beginnings.